KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Other Operating Expenses (2016 - 2024)

Exact Sciences (EXAS) has disclosed Other Operating Expenses for 15 consecutive years, with $2.6 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Operating Expenses fell 59.88% to $2.6 million in Q4 2024 year-over-year; TTM through Sep 2025 was $2.6 million, a 80.29% decrease, with the full-year FY2024 number at $9.2 million, down 88.27% from a year prior.
  • Other Operating Expenses was $2.6 million for Q4 2024 at Exact Sciences, down from $3.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $427.4 million in Q4 2021 to a low of -$268000.0 in Q1 2024.
  • A 5-year average of $201.6 million and a median of $195.4 million in 2020 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: surged 303.09% in 2020, then tumbled 95.7% in 2024.
  • Exact Sciences' Other Operating Expenses stood at $169.5 million in 2020, then soared by 152.2% to $427.4 million in 2021, then decreased by 14.58% to $365.1 million in 2022, then tumbled by 98.25% to $6.4 million in 2023, then plummeted by 59.88% to $2.6 million in 2024.
  • Per Business Quant, the three most recent readings for EXAS's Other Operating Expenses are $2.6 million (Q4 2024), $3.1 million (Q3 2024), and $3.8 million (Q2 2024).